Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Longitudinal Studies01:26

Longitudinal Studies

238
Longitudinal studies are also widely used in other medical and social science fields. For instance, in cardiovascular research, they can monitor patients' health over decades to identify risk factors for heart disease, such as high cholesterol or smoking, and evaluate the long-term effectiveness of preventive measures. Similarly, in mental health studies, researchers might follow individuals from adolescence into adulthood to understand the development and progression of conditions like...
238
Longitudinal Research02:20

Longitudinal Research

12.5K
Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
12.5K
Steps in Outbreak Investigation01:18

Steps in Outbreak Investigation

199
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
199
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

395
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
395
Improving Translational Accuracy02:07

Improving Translational Accuracy

11.9K
Base complementarity between the three base pairs of mRNA codon and the tRNA anticodon is not a failsafe mechanism. Inaccuracies can range from a single mismatch to no correct base pairing at all. The free energy difference between the correct and nearly correct base pairs can be as small as 3 kcal/ mol. With complementarity being the only proofreading step, the estimated error frequency would be one wrong amino acid in every 100 amino acids incorporated. However, error frequencies observed in...
11.9K
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

86
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
86

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Life Stressors in Young Americans are Linked via Asymmetric U-Shapes to Mental Health Severity.

Research square·2026
Same author

A century of suicide: Insights from long-term data in the United States.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

The doctor is not in, but the Chatbot is: Utah's experience regulating mental health AI.

NPJ digital medicine·2026
Same author

Predicting the onset of internalizing disorders in early adolescence using deep learning optimized with AI.

Frontiers in psychiatry·2025
Same author

<i>RiskPath</i>: Explainable deep learning for multistep biomedical prediction in longitudinal data.

medRxiv : the preprint server for health sciences·2024
Same author

Selectively predicting the onset of ADHD, oppositional defiant disorder, and conduct disorder in early adolescence with high accuracy.

Frontiers in psychiatry·2023

関連する実験動画

Updated: Sep 10, 2025

Author Spotlight: Advancing Alzheimer's Research &#8211; Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.3K

RiskPath: 多段階の生物医学予測のための説明可能なディープラーニング

Nina de Lacy1, Michael Ramshaw1, Wai Yin Lam1

  • 1Department of Psychiatry, University of Utah, Salt Lake City, UT 84108, USA.

Patterns (New York, N.Y.)
|August 22, 2025
PubMed
まとめ

RiskPathは 病気のリスクの分層化のための 新しい説明可能な AI ツールボックスです 先進的なタイムシリーズAIを使って 結果を予測し 予測要素の重要性を時間とともにマップします

科学分野:

  • 人工知能
  • 生物医学情報学
  • コンピュータ生物学

背景:

  • 多因子疾患は リスクが時間とともに 複雑に相互作用することで生じます
  • タイムシリーズのAI方法は,縦断的なデータから病気の結果を予測するのに有望です.
  • 現在のリスク分層化ツールは,モデルの複雑さ,サイズ,説明性といった課題に直面しています.

研究 の 目的:

  • 病気のリスクの階層化のための説明可能なAIツールボックスであるRiskPathを導入します
  • 縦断的なコホート研究に合わせた高度なタイムシリーズの方法を提供すること.
  • 臨床リスク予測におけるAIモデルの可用性と解釈性を向上させる.

主な方法:

  • 先進的なタイムシリーズ分析を統合したAIツールボックスであるRiskPathの開発.
  • モデル設計とパフォーマンスチューニングの理論に基づいた最適化の組み込み.
  • 予測要因の重要性と時間的なリスク要因を視覚化するためのモジュールを実装する.
  • 予測器を除去することで,コンパクトで臨床的に適用可能なモデルを作成する機能.

主要な成果:

  • RiskPathは,リスクの階層化におけるタイムシリーズのデータを説明可能なAIで提供しています.
キーワード:
制限された最適化累積リスク説明可能なディープラーニング特徴の消去縦軸コホートデータ性能と複雑性のトレードオフリスク経路タイムシリーズの学習

さらに関連する動画

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

892
Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

575

関連する実験動画

Last Updated: Sep 10, 2025

Author Spotlight: Advancing Alzheimer's Research &#8211; Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.3K
Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

892
Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

575
  • このツールボックスでは,病気の進行過程におけるダイナミックな予測要因の重要性のマッピングが可能です.
  • 患者は病気のリスクに影響を与える 重要な期間を特定できます
  • コンパクトなモデルは予測性能に最小限の影響で生成できます.
  • 結論:

    • RiskPathは,現在のAI主導のリスク分層化ツールの限界を解決します.
    • このツールボックスにより,縦断的な健康データに関する解釈可能なAIモデルの開発と展開が容易になります.
    • RiskPathは,疾患の経路とリスク因子に関する洞察を提供することで,臨床的応用をサポートします.